Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 8Unknown 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 14Lymphoma 10Lymphoma, Large B-Cell, Diffuse 8Triple Negative Breast Neoplasms 6Lymphoma, Follicular 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Carcinoma, Hepatocellular 3Waldenstrom Macroglobulinemia 2Sarcoma 2Ovarian Neoplasms 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Extranodal NK-T-Cell 2Immunoblastic Lymphadenopathy 2Enteropathy-Associated T-Cell Lymphoma 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Vomiting 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Sezary Syndrome 1Rhabdomyosarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Platinum-Refractory Fallopian Tube Carcinoma 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

Topotecan 2Ifosfamide 2Etoposide 2trioctyl phosphine oxide 1indolepropanol phosphate 1imetelstat 1Vincristine 1Transplantation 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Minocycline 1Melphalan 1Heparin 1Glutamine 1GRN163L peptide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neuroectodermal Tumors, Primitive, Peripheral × Doxorubicin × Clear all
NCT00334867 2013-06-28

Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma

Children's Oncology Group

Phase 3 Withdrawn
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡